HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julieta Afonso Selected Research

Neoplasms (Cancer)

11/2023Effects of Lactate Transport Inhibition by AZD3965 in Muscle-Invasive Urothelial Bladder Cancer.
3/2023Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review.
2/2023Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy.
1/2023Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study.
1/2023Clinical and Prognostic Impact of the Warburg Effect in Esophageal Carcinoma: Monocarboxylate Transporters as Candidates for Therapeutic Targeting.
1/2023Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?
12/2021In Vivo Anticancer Activity of AZD3965: A Systematic Review.
1/2020Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy.
1/2020Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.
1/2020Lactate and Lactate Transporters as Key Players in the Maintenance of the Warburg Effect.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julieta Afonso Research Topics

Disease

13Neoplasms (Cancer)
11/2023 - 11/2015
6Urinary Bladder Neoplasms (Bladder Cancer)
04/2024 - 08/2009
5Carcinoma (Carcinomatosis)
02/2023 - 08/2009
4Neoplasm Metastasis (Metastasis)
03/2023 - 04/2013
2Wounds and Injuries (Trauma)
04/2024 - 11/2023
2Acidosis
11/2023 - 01/2020
1Varicose Veins (Varicose Vein)
04/2024
1Hemorrhage
11/2023
1Inflammation (Inflammations)
11/2023
1Triple Negative Breast Neoplasms
11/2023
1Esophageal Squamous Cell Carcinoma
01/2023
1Esophageal Neoplasms (Esophageal Cancer)
01/2023
1Hypoxia (Hypoxemia)
01/2023
1Lymphoma (Lymphomas)
06/2019
1Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2019
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2019

Drug/Important Bio-Agent (IBA)

9Lactic Acid (Lactate)FDA LinkGeneric
11/2023 - 06/2019
6Glucose (Dextrose)FDA LinkGeneric
02/2023 - 06/2019
5PlatinumIBA
04/2024 - 11/2015
4Oxygen (Dioxygen)IBA
03/2023 - 01/2020
4Proteins (Proteins, Gene)FDA Link
02/2023 - 04/2013
3AZD3965IBA
11/2023 - 06/2019
3Biomarkers (Surrogate Marker)IBA
02/2023 - 06/2019
2Eosine Yellowish-(YS) (Eosin)IBA
04/2024 - 11/2023
2Cisplatin (Platino)FDA LinkGeneric
04/2024 - 11/2015
1CytokinesIBA
11/2023
1Hematoxylin (Haematoxylon)IBA
11/2023
1Small Interfering RNA (siRNA)IBA
11/2023
1Indicators and Reagents (Reagents)IBA
03/2023
1HexokinaseIBA
02/2023
1Protons (Proton)IBA
01/2023
1Protein Isoforms (Isoforms)IBA
01/2023
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1raf KinasesIBA
04/2013
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2009
1Vascular Endothelial Growth Factor CIBA
11/2009
1AntibodiesIBA
11/2009
1Sirolimus (Rapamycin)FDA Link
08/2009

Therapy/Procedure

8Therapeutics
04/2024 - 01/2020
3Drug Therapy (Chemotherapy)
02/2023 - 11/2015
1Ligation
04/2024
1Immunotherapy
01/2020
1Cystectomy
11/2009